keyword
Keywords Brain glioblastoma lung cancer...

Brain glioblastoma lung cancer breast cancer

https://read.qxmd.com/read/38429268/otud4-promotes-the-progression-of-glioblastoma-by-deubiquitinating-cdk1-and-activating-mapk-signaling-pathway
#1
JOURNAL ARTICLE
Mingxin Ci, Gaichao Zhao, Chongyang Li, Ruochen Liu, Xiaosong Hu, Jun Pan, Yang Shen, Guanghui Zhang, Yongsen Li, Li Zhang, Ping Liang, Hongjuan Cui
Glioblastoma, IDH-Wild type (GBM, CNS WHO Grade 4) is a highly heterogeneous and aggressive primary malignant brain tumor with high morbidity, high mortality, and poor patient prognosis. The global burden of GBM is increasing notably due to limited treatment options, drug delivery problems, and the lack of characteristic molecular targets. OTU deubiquitinase 4 (OTUD4) is a potential predictive factor for several cancers such as breast cancer, liver cancer, and lung cancer. However, its function in GBM remains unknown...
March 1, 2024: Cell Death & Disease
https://read.qxmd.com/read/38391974/signaling-pathways-of-axl-receptor-tyrosine-kinase-contribute-to-the-pathogenetic-mechanisms-of-glioblastoma
#2
REVIEW
Alberto Repici, Alessio Ardizzone, Fabiola De Luca, Lorenzo Colarossi, Angela Prestifilippo, Gabriele Pizzino, Irene Paterniti, Emanuela Esposito, Anna Paola Capra
Brain tumors are a diverse collection of neoplasms affecting the brain with a high prevalence rate in people of all ages around the globe. In this pathological context, glioblastoma, a form of glioma that belongs to the IV-grade astrocytoma group, is the most common and most aggressive form of the primary brain tumors. Indeed, despite the best treatments available including surgery, radiotherapy or a pharmacological approach with Temozolomide, glioblastoma patients' mortality is still high, within a few months of diagnosis...
February 19, 2024: Cells
https://read.qxmd.com/read/38321173/systematic-pan-cancer-analyses-of-the-potential-function-of-the-golgi-scaffold-protein-paqr3
#3
JOURNAL ARTICLE
Zhe-Nan Ling, Lian-Lian Hong, Jian Wu, Zhi-Qiang Ling
Progesterone and AdipoQ Receptor 3 (PAQR3) is a member of the AdipoQ receptor. Our previous studies have found that PAQR3 plays a role as a candidate inhibitor in cardiac adenocarcinoma, breast cancer, gastric cancer and colorectal cancer, but the systematic analysis of PAQR3 in tumors is currently lacking. The objective of this study was to investigate the prognostic and therapeutic value of PAQR3 in 31 tumors. Through the analysis of TCGA, UALCAN, GEO, GEPIA2, TIMER, Kaplan-Meier plotter, TISIDB and other databases, it was found that the expression level of PAQR3 changed significantly in different tumor types, and the expression level of Neuroblastoma was very high...
February 6, 2024: Scientific Reports
https://read.qxmd.com/read/38007705/apobec3c-is-a-novel-target-for-the-immune-treatment-of-lower-grade-gliomas
#4
JOURNAL ARTICLE
Shufa Zhao, Yuntao Li, Jie Xu, Liang Shen
BACKGROUND: Apolipoprotein B mRNA editing catalytic polypeptide-like (APOBEC) type 3C (A3C) has been identified as a cancer molecular biomarker in the past decade. However, the practical role of A3C in lower-grade gliomas (LGGs) in improving the clinical outcome remains unclear. This study aims to discuss the function of A3C in immunotherapy in LGGs. METHODS: The RNA-Sequencing (RNA-seq) and corresponding clinical data were extracted from UCSC Xena and the results were verified in the Chinese Glioma Genome Atlas (CGGA)...
November 26, 2023: Neurological Research
https://read.qxmd.com/read/37936683/the-immune-cell-landscape-of-glioblastoma-patients-highlights-a-myeloid-enriched-and-immune-suppressed-microenvironment-compared-to-metastatic-brain-tumors
#5
JOURNAL ARTICLE
Beatrice Musca, Maria Giovanna Russo, Ada Tushe, Sara Magri, Greta Battaggia, Laura Pinton, Camilla Bonaudo, Alessandro Della Puppa, Susanna Mandruzzato
INTRODUCTION: Brain metastases (BrM), which commonly arise in patients with melanoma, breast cancer and lung cancer, are associated with a poor clinical prognosis. In this context, the tumor microenvironment (TME) plays an important role since it either promotes or inhibits tumor progression. Our previous studies have characterized the immunosuppressive microenvironment of glioblastoma (GBM). The aim of this study is to compare the immune profiles of BrM and GBM in order to identify potential differences that may be exploited in their differential treatment...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37818043/multiomics-and-bioinformatics-identify-differentially-expressed-effectors-in-the-brain-of-toxoplasma-gondii-infected-masked-palm-civet
#6
JOURNAL ARTICLE
Hao Yuan, Tiantian Jiang, Wei-Dong Zhang, Zipeng Yang, Shengjun Luo, Xiaohu Wang, Xiaojing Zhu, Shuting Qi, Yasser S Mahmmod, Xiu-Xiang Zhang, Zi-Guo Yuan
INTRODUCTION: The masked palm civet ( Paguma larvata ) serves as a reservoir in transmitting pathogens, such as Toxoplasma gondii , to humans. However, the pathogenesis of T. gondii infection in masked palm civets has not been explored. We studied the molecular changes in the brain tissue of masked palm civets chronically infected with T. gondii ME49. METHODS: The differentially expressed proteins in the brain tissue were investigated using iTRAQ and bioinformatics...
2023: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/37641236/design-and-discovery-of-novel-pyrazole-pyrrolopyrimidine-derivatives-as-anti-glioma-agents-via-promoting-apoptosis-inhibiting-cell-cycle-and-egfr-tk
#7
JOURNAL ARTICLE
Yufu Zhang, Li Gao
Glioma is an aggressive type of brain malignancy responsible for significant morbidity and mortality. In the current scenario, epidermal growth factor receptor (EGFR) kinases targeted therapy showed significant benefits in glioma patients. Therefore, in the present study, we intend to investigate the anti-glioma potential of a novel class of pyrazole-pyrrolopyrimidine derivatives and their mechanism of action. The compounds will be synthesized in a straight-forward synthetic route in excellent yields and subsequently tested for EGFR kinase inhibition...
August 28, 2023: Chemical Biology & Drug Design
https://read.qxmd.com/read/37627957/sternum-metastases-from-case-identifying-strategy-to-multidisciplinary-management
#8
REVIEW
Mara Carsote, Dana Terzea, Florina Vasilescu, Anca-Pati Cucu, Adrian Ciuche, Claudiu Nistor
We aimed to overview the most recent data on sternal metastases from a multidisciplinary approach (diagnosis strategies, outcome, and histological reports). This narrative review based on a PubMed search (between January 2020 and 22 July 2023) using key words such as "sternal", "manubrium", and "metastasis" within the title and/or abstract only included original papers that specifically addressed secondary sternal spreading of cancer in adults, for a total of 48 original articles (14 studies and 34 single case reports)...
August 17, 2023: Diagnostics
https://read.qxmd.com/read/37479733/single-cell-sequencing-reveals-the-landscape-of-the-human-brain-metastatic-microenvironment
#9
JOURNAL ARTICLE
Qianqian Song, Jimmy Ruiz, Fei Xing, Hui-Wen Lo, Lou Craddock, Ashok K Pullikuth, Lance D Miller, Michael H Soike, Stacey S O'Neill, Kounosuke Watabe, Michael D Chan, Jing Su
Brain metastases is the most common intracranial tumor and account for approximately 20% of all systematic cancer cases. It is a leading cause of death in advanced-stage cancer, resulting in a five-year overall survival rate below 10%. Therefore, there is a critical need to identify effective biomarkers that can support frequent surveillance and promote efficient drug guidance in brain metastasis. Recently, the remarkable breakthroughs in single-cell RNA-sequencing (scRNA-seq) technology have advanced our insights into the tumor microenvironment (TME) at single-cell resolution, which offers the potential to unravel the metastasis-related cellular crosstalk and provides the potential for improving therapeutic effects mediated by multifaceted cellular interactions within TME...
July 21, 2023: Communications Biology
https://read.qxmd.com/read/36839682/investigating-the-effects-of-olaparib-on-the-susceptibility-of-glioblastoma-multiforme-tumour-cells-to-natural-killer-cell-mediated-responses
#10
JOURNAL ARTICLE
Jennifer Moran, Eimear Mylod, Laura E Kane, Caroline Marion, Emily Keenan, Marianna Mekhaeil, Joanne Lysaght, Kumlesh K Dev, Jacintha O'Sullivan, Melissa J Conroy
Glioblastoma multiforme (GBM) is the most common adult primary brain malignancy, with dismal survival rates of ~14.6 months. The current standard-of-care consists of surgical resection and chemoradiotherapy, however the treatment response is limited by factors such as tumour heterogeneity, treatment resistance, the blood-brain barrier, and immunosuppression. Several immunotherapies have undergone clinical development for GBM but demonstrated inadequate efficacy, yet future combinatorial approaches are likely to hold more promise...
January 20, 2023: Pharmaceutics
https://read.qxmd.com/read/36768923/reactivity-graph-yields-interpretable-igm-repertoire-signatures-as-potential-tumor-biomarkers
#11
JOURNAL ARTICLE
Dilyan Ferdinandov, Viktor Kostov, Maya Hadzhieva, Velizar Shivarov, Peter Petrov, Assen Bussarsky, Anastas Dimitrov Pashov
Combining adaptive and innate immunity induction modes, the repertoire of immunoglobulin M (IgM) can reflect changes in the internal environment including malignancies. Previously, it was shown that a mimotope library reflecting the public IgM repertoire of healthy donors (IgM IgOme) can be mined for efficient probes of tumor biomarker antibody reactivities. To better explore the interpretability of this approach for IgM, solid tumor-related profiles of IgM reactivities to linear epitopes of actual tumor antigens and viral epitopes were studied...
January 30, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36557987/effect-of-copper-chelators-via-the-tgf-%C3%AE-signaling-pathway-on-glioblastoma-cell-invasion
#12
JOURNAL ARTICLE
Heabin Kim, Seonmi Jo, In-Gyu Kim, Rae-Kwon Kim, Yeon-Jee Kahm, Seung-Hyun Jung, Jei Ha Lee
Glioblastoma multiforme (GBM) is a fast-growing and aggressive type of brain cancer. Unlike normal brain cells, GBM cells exhibit epithelial-mesenchymal transition (EMT), which is a crucial biological process in embryonic development and cell metastasis, and are highly invasive. Copper reportedly plays a critical role in the progression of a variety of cancers, including brain, breast, and lung cancers. However, excessive copper is toxic to cells. D-penicillamine (DPA) and triethylenetetramine (TETA) are well-known copper chelators and are the mainstay of treatment for copper-associated diseases...
December 13, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/36466552/comprehensive-pan-cancer-analysis-of-gins2-for-human-tumour-prognosis-and-as-an-immunological-biomarker
#13
JOURNAL ARTICLE
Wei Meng, Zhaosheng Jiang, Xiang Zhang, Bo Cai, Limin Ma, Yangbo Guan
BACKGROUND: In recent years, more and more reports have shown that GINS complex subunit 2 (GINS2) plays an important role in the occurrence and progression of tumours. However, there is a lack of comprehensive and systematic research on its prognostic and immune effects in pan-cancer. Therefore, this study is aimed at investigating the prognostic value and immune-related role of GINS2 in human tumours and providing a comprehensive understanding of its carcinogenic mechanism in pan-cancer...
2022: Computational and Mathematical Methods in Medicine
https://read.qxmd.com/read/36380859/circulating-tumor-cells-and-extracellular-vesicles-as-liquid-biopsy-markers-in-neuro-oncology-prospects-and-limitations
#14
JOURNAL ARTICLE
Manfred Westphal, Klaus Pantel, Franz L Ricklefs, Cecile Maire, Sabine Riethdorf, Malte Mohme, Harriet Wikman, Katrin Lamszus
For many tumor entities, tumor biology and response to therapy are reflected by components that can be detected and captured in the blood stream. The so called "liquid biopsy" has been stratified over time into the analysis of circulating tumor cells (CTC), extracellular vesicles (EVs), and free circulating components such as cell-free nucleic acids or proteins. In neuro-oncology, two distinct areas need to be distinguished, intrinsic brain tumors and tumors metastatic to the brain. For intrinsic brain tumors, specifically glioblastoma, CTCs although present in low abundance, contain highly relevant, yet likely incomplete biological information for the whole tumor...
November 2022: Neuro-oncology advances
https://read.qxmd.com/read/36282234/tas2940-a-novel-brain-penetrable-pan-erbb-inhibitor-for-tumors-with-her2-and-egfr-aberrations
#15
JOURNAL ARTICLE
Kei Oguchi, Hikari Araki, Shingo Tsuji, Masayuki Nakamura, Akihiro Miura, Kaoru Funabashi, Akiko Osada, Sakiho Tanaka, Takamasa Suzuki, Susumu S Kobayashi, Shinji Mizuarai
Genetic alterations in HER2/EGFR are commonly associated with breast and lung cancers and glioblastomas. Cancers with ERBB deregulation are highly metastatic and can cause primary brain tumors. Currently, no pan-ERBB inhibitor with remarkable brain penetration is available. Here, TAS2940, a novel irreversible pan-ERBB inhibitor with improved brain penetrability, was evaluated for its efficacy against several ERBB aberrant cancer models. The selectivity of TAS2940 was evaluated via enzymatic kinase assays. The inhibitory effects of TAS2940 against ERBB genetic alterations were examined using MCF10A cells expressing various HER2 or EGFR mutations and other generic cell lines harboring deregulated ERBB expression...
October 25, 2022: Cancer Science
https://read.qxmd.com/read/36033522/investigational-cyclin-dependent-kinase-4-6-inhibitor-glr2007-demonstrates-activity-against-isocitrate-dehydrogenase-wild-type-glioblastoma-and-other-solid-tumors-in-mice-xenograft-models
#16
JOURNAL ARTICLE
Lei Yin, Zhenglin Yao, Yue Wang, Michelle Mazuranic
Cyclin-dependent kinases, CDK4 and CDK6, are essential in regulating the cell cycle, which is disrupted in cancers like isocitrate dehydrogenase wild-type glioblastoma (GBM). Currently marketed CDK4/6 inhibitors, including abemaciclib, have shown preclinical efficacy in solid tumors, but factors such as poor blood-brain barrier (BBB) penetration limit their efficacy in GBM. GLR2007 is an investigational CDK4/6 inhibitor with the potential for improved BBB penetration. In vitro assays were used to assess the potency and inhibition of CDK4/6 enzymatic activity of GLR2007...
2022: Frontiers in Oncology
https://read.qxmd.com/read/36031762/versatile-use-of-carmofur-a-comprehensive-review-of-its-chemistry-and-pharmacology
#17
REVIEW
Mohammad Mohiminul Islam, Shama P Mirza
Carmofur, 1-hexylcarbamoyl-5-fluorouracil (HCFU) is an antineoplastic drug, which has been in clinics in Japan since 1981 for the treatment of colorectal cancer. Subsequently, it was also introduced in China, Korea, and Finland. Besides colorectal cancer, it has also shown antitumor activity in other cancers such as breast, head and neck, pancreatic, gastrointestinal, and solid brain tumors. A prodrug of 5-fluorouracil (5-FU), carmofur has shown better gastrointestinal stability and superior antiproliferative activity compared to its active counterpart 5-FU...
August 28, 2022: Drug Development Research
https://read.qxmd.com/read/35978522/the-emerging-role-of-27-hydroxycholesterol-in-cancer-development-and-progression-an-update
#18
REVIEW
Saade Abdalkareem Jasim, Hamzah H Kzar, Mohammed Haider Hamad, Irfan Ahmad, Moaed E Al-Gazally, Shukhrat Ziyadullaev, R Sivaraman, Mohammed Abed Jawad, Ali Thaeer Hammid, Khulood H Oudaha, Sajad Karampoor, Rasoul Mirzaei
Oxysterols are cholesterol metabolites generated in the liver and other peripheral tissues as a mechanism of removing excess cholesterol. Oxysterols have a wide range of biological functions, including the regulation of sphingolipid metabolism, platelet aggregation, and apoptosis. However, it has been found that metabolites derived from cholesterol play essential functions in cancer development and immunological suppression. In this regard, research indicates that 27-hydroxycholesterol (27-HC) might act as an estrogen, promoting the growth of estrogen receptor (ER) positive breast cancer cells...
September 2022: International Immunopharmacology
https://read.qxmd.com/read/35832625/identifies-microtubule-binding-protein-cspp1-as-a-novel-cancer-biomarker-associated-with-ferroptosis-and-tumor-microenvironment
#19
JOURNAL ARTICLE
Wenwen Wang, Jingjing Zhang, Yuqing Wang, Yasi Xu, Shirong Zhang
Centrosome and spindle pole-associated protein ( CSPP1 ) is a centrosome and microtubule-binding protein that plays a role in cell cycle-dependent cytoskeleton organization and cilia formation. Previous studies have suggested that CSPP1 plays a role in tumorigenesis; however, no pan-cancer analysis has been performed. This study systematically investigates the expression of CSPP1 and its potential clinical outcomes associated with diagnosis, prognosis, and therapy. CSPP1 is widely present in tissues and cells and its aberrant expression serves as a diagnostic biomarker for cancer...
2022: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/35782741/comprehensive-analysis-of-the-novel-omicron-receptor-axl-in-cancers
#20
JOURNAL ARTICLE
Wei-Na Zhang, Xue-Ping Li, Peng-Fei Wang, Lu Zhu, Xin-Hua Xiao, Yu-Jun Dai
The SARS-CoV-2 is constantly mutating, and the new coronavirus such as Omicron has spread to many countries around the world. Anexelekto (AXL) is a transmembrane protein with biological functions such as promoting cell growth, migration, aggregation, metastasis and adhesion, and plays an important role in cancers and coronavirus disease 2019 (COVID-19). Unlike angiotensin-converting enzyme 2 (ACE2), AXL was highly expressed in respiratory system cells. In this study, we verified the AXL expression in cancer and normal tissues and found AXL expression was strongly correlated with cancer prognosis, tumor mutation burden (TMB), the microsatellite instability (MSI) in most tumor types...
2022: Computational and Structural Biotechnology Journal
keyword
keyword
163667
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.